Suven Life Sciences Ltd.

NSE: SUVEN | BSE: 530239 | ISIN: INE495B01038 | Industry: Healthcare Services
|
125.0500 -0.95 (-0.75%)
NSE Mar 21, 2025 15:31 PM
Volume: 318.1K
 

125.05
-0.75%
Karvy
The revenue decline of 14% on QoQ basis and 15% on YoY basis was on expected lines on account of absence of prelaunch supplies last year and high value product mix in the last quarter. The same also impacted the asset utilization of the company impacting the margins in Q4FY15 compared to earlier periods.
Suven Life Sciences Ltd. is trading above its 50 day SMA of 122.3
More from Suven Life Sciences Ltd.
Recommended